ADPT Adaptive Biotechnologies Corp
Nasdaq · SEC CIK 1478320 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $122.01M 70 sales by 11 insiders
- Filings on record
- 204 since 2021-07-01, latest 2026-09-18 20:17
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| ROBINS HARLAN S | CSO | — | $29.65M |
| BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| LO FRANCIS | CHRO | — | $13.21M |
| PISKEL KYLE | CFO | — | $3.58M |
| NEUPERT PETER M | Dir | — | $3.14M |
| GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 298
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-06 | 2026-01-02 | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $16.08 | -3,125 | 316.0K | -1.0% | -$50.2K |
| D | 2026-01-06 | 2026-01-02 | ADPT | LO FRANCIS | CHRO | M - OptEx | $3.99 | +3,125 | 319.1K | +1.0% | +$12.5K |
| D | 2025-12-29 | 2025-12-22 | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $17.50 | -4,394 | 316.0K | -1% | -$76.9K |
| DM | 2025-12-29 | 2025-12-22 | ADPT | LO FRANCIS | CHRO | M - OptEx | $7.18 | +4,394 | 319.3K | +1% | +$31.5K |
| DM | 2025-12-17 | 2025-12-15 | ADPT | LO FRANCIS | CHRO | M - OptEx | $6.37 | +97.0K | 429.9K | +29% | +$617.8K |
| D | 2025-12-17 | 2025-12-15 | ADPT | LO FRANCIS | CHRO | S - Sale+OE | $15.57 | -113.9K | 316.0K | -26% | -$1.77M |
| 2025-12-12 | 2025-12-10 | ADPT | HERSHBERG ROBERT | Dir | S - Sale | $16.00 | -23.0K | 46.7K | -33% | -$367.5K | |
| DM | 2025-12-08 | 2025-12-04 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | M - OptEx | $8.24 | +12.6K | 305.2K | +4% | +$103.8K |
| D | 2025-12-08 | 2025-12-04 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale+OE | $16.85 | -12.6K | 296.8K | -4% | -$212.4K |
| M | 2025-12-05 | 2025-12-03+ | ADPT | ROBINS HARLAN S | CSO | S - Sale | $18.07 | -37.2K | 1.23M | -3% | -$672.5K |
| D | 2025-12-02 | 2025-11-28 | ADPT | PISKEL KYLE | CFO | S - Sale+OE | $19.50 | -162.8K | 216.6K | -43% | -$3.17M |
| DM | 2025-12-02 | 2025-11-28 | ADPT | PISKEL KYLE | CFO | M - OptEx | $11.38 | +110.1K | 285.1K | +63% | +$1.25M |
| M | 2025-12-01 | 2025-11-26+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $19.10 | -160.7K | 2.83M | -5% | -$3.07M |
| DM | 2025-11-24 | 2025-11-20+ | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | M - OptEx | $8.75 | +510.5K | 594.7K | +606% | +$4.46M |
| DM | 2025-11-24 | 2025-11-20+ | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale+OE | $16.73 | -606.4K | 296.8K | -67% | -$10.14M |
| 2025-11-18 | 2025-11-17 | ADPT | PISKEL KYLE | CFO | S - Sale | $14.05 | -238 | 269.3K | -0.1% | -$3,344 | |
| M | 2025-11-12 | 2025-11-10+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $14.73 | -89.3K | 2.87M | -3% | -$1.32M |
| 2025-11-12 | 2025-11-10 | ADPT | ROBINS HARLAN S | CSO | S - Sale | $14.82 | -10.0K | 1.27M | -0.8% | -$148.2K | |
| A | 2025-05-20 | 2025-05-16 | ADPT | PISKEL KYLE | CFO | S - Sale | $8.89 | -1,929 | 269.6K | -0.7% | -$17.1K |
| 2025-05-19 | 2025-05-16 | ADPT | PISKEL KYLE | CFO | S - Sale | $8.89 | -1,929 | 277.4K | -0.7% | -$17.1K | |
| 2025-05-19 | 2025-05-15 | ADPT | PISKEL KYLE | CFO | A - Grant | $0.00 | +7,815 | 279.3K | +3% | $0 | |
| D | 2025-05-05 | 2025-05-01 | ADPT | ROBINS HARLAN S | CSO | S - Sale+OE | $7.35 | -68.4K | 1.28M | -5% | -$502.8K |
| D | 2025-05-05 | 2025-05-01 | ADPT | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +68.4K | 1.35M | +5% | +$432.4K |
| D | 2025-03-26 | 2025-03-24 | ADPT | ROBINS HARLAN S | CSO | S - Sale+OE | $9.00 | -1,698 | 1.28M | -0.1% | -$15.3K |
| D | 2025-03-26 | 2025-03-24 | ADPT | ROBINS HARLAN S | CSO | M - OptEx | $6.32 | +1,698 | 1.28M | +0.1% | +$10.7K |
| 2025-03-17 | 2025-03-13 | ADPT | GRIFFIN MICHELLE RENEE | Dir | S - Sale | $7.19 | -36.3K | 15.4K | -70% | -$260.9K | |
| D | 2025-03-17 | 2025-03-14 | ADPT | PISKEL KYLE | CFO | M - OptEx | $6.32 | +2,500 | 271.5K | +0.9% | +$15.8K |
| 2025-03-12 | 2025-03-12 | ADPT | HERSHBERG ROBERT | Dir | S - Sale | $7.59 | -53.0K | 69.7K | -43% | -$402.3K | |
| D | 2025-03-12 | 2025-03-10 | ADPT | NEUPERT PETER M | Dir | S - Sale+OE | $7.05 | -10.0K | 224.7K | -4% | -$70.5K |
| D | 2025-03-12 | 2025-03-10 | ADPT | NEUPERT PETER M | Dir | M - OptEx | $4.07 | +50.0K | 234.7K | +27% | +$203.5K |
| D | 2025-03-06 | 2025-03-04 | ADPT | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +15.4K | 67.3K | +30% | $0 |
| D | 2025-03-06 | 2025-03-06 | ADPT | GRIFFIN MICHELLE RENEE | Dir | S - Sale | $7.94 | -15.7K | 51.7K | -23% | -$124.4K |
| D | 2025-03-06 | 2025-03-04 | ADPT | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +15.4K | 122.7K | +14% | $0 |
| M | 2025-03-06 | 2025-03-05 | ADPT | PISKEL KYLE | CFO | S - Sale | $6.98 | -10.3K | 276.0K | -4% | -$72.1K |
| 2025-03-06 | 2025-03-04 | ADPT | PISKEL KYLE | CFO | A - Grant | $0.00 | +125.0K | 279.3K | +81% | $0 | |
| D | 2025-03-06 | 2025-03-04 | ADPT | OWEN KATEY EINTERZ | Dir | A - Grant | $0.00 | +15.4K | 72.6K | +27% | $0 |
| D | 2025-03-06 | 2025-03-04 | ADPT | Pellini Michael J | Dir | A - Grant | $0.00 | +15.4K | 69.7K | +28% | $0 |
| D | 2025-03-06 | 2025-03-04 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +120.0K | 373.3K | +47% | $0 |
| D | 2025-03-06 | 2025-03-05 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $6.98 | -26.0K | 347.2K | -7% | -$181.6K |
| M | 2025-03-06 | 2025-03-04+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +602.1K | 3.06M | +24% | $0 |
| M | 2025-03-06 | 2025-03-05+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $7.29 | -219.6K | 2.96M | -7% | -$1.60M |
| D | 2025-03-06 | 2025-03-04 | ADPT | NEUPERT PETER M | Dir | A - Grant | $0.00 | +15.4K | 184.7K | +9% | $0 |
| 2025-03-06 | 2025-03-04 | ADPT | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +355.0K | 1.38M | +35% | $0 | |
| M | 2025-03-06 | 2025-03-05 | ADPT | ROBINS HARLAN S | CSO | S - Sale | $6.99 | -96.7K | 1.34M | -7% | -$675.2K |
| D | 2025-03-06 | 2025-03-04 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | A - Grant | $0.00 | +110.0K | 437.4K | +34% | $0 |
| DM | 2025-03-06 | 2025-03-05 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale | $6.98 | -44.7K | 392.7K | -10% | -$311.8K |
| 2025-03-06 | 2025-03-04 | ADPT | RUBINSTEIN JULIE | Pres, COO | A - Grant | $0.00 | +175.0K | 647.8K | +37% | $0 | |
| M | 2025-03-06 | 2025-03-05 | ADPT | RUBINSTEIN JULIE | Pres, COO | S - Sale | $6.98 | -59.5K | 588.2K | -9% | -$415.5K |
| D | 2025-03-06 | 2025-03-04 | ADPT | LO FRANCIS | CHRO | A - Grant | $0.00 | +100.0K | 353.7K | +39% | $0 |
| DM | 2025-03-06 | 2025-03-05 | ADPT | LO FRANCIS | CHRO | S - Sale | $6.99 | -20.9K | 346.6K | -6% | -$145.8K |
| DM | 2025-02-21 | 2025-02-19+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | M - OptEx | $6.32 | +285.2K | 2.68M | +12% | +$1.80M |
| DM | 2025-02-21 | 2025-02-19+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale+OE | $8.45 | -285.2K | 2.58M | -10% | -$2.41M |
| DM | 2025-02-18 | 2025-02-13+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | M - OptEx | $6.32 | +470.4K | 2.74M | +21% | +$2.97M |
| DM | 2025-02-18 | 2025-02-13+ | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale+OE | $8.47 | -470.4K | 2.58M | -15% | -$3.99M |
| 2024-11-19 | 2024-11-18 | ADPT | PISKEL KYLE | CFO | S - Sale | $4.98 | -248 | 154.3K | -0.2% | -$1,235 | |
| D | 2024-10-10 | 2024-10-08 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | M - OptEx | $1.98 | +5,000 | 253.3K | +2% | +$9,900 |
| 2024-08-23 | 2024-08-22 | ADPT | Taylor Stacy L | SVP, GC | S - Sale | $4.50 | -26.9K | 139.4K | -16% | -$121.1K | |
| 2024-05-17 | 2024-05-15 | ADPT | PISKEL KYLE | CFO | A - Grant | $0.00 | +31.3K | 154.6K | +25% | $0 | |
| D | 2024-03-13 | 2024-03-12 | ADPT | NEUPERT PETER M | Dir | M - OptEx | $0.84 | +15.0K | 169.3K | +10% | +$12.6K |
| D | 2024-03-06 | 2024-03-04 | ADPT | HERSHBERG ROBERT | Dir | A - Grant | $0.00 | +31.3K | 107.3K | +41% | $0 |
| D | 2024-03-06 | 2024-03-04 | ADPT | Pellini Michael J | Dir | A - Grant | $0.00 | +31.3K | 54.3K | +136% | $0 |
| D | 2024-03-06 | 2024-03-04 | ADPT | Taylor Stacy L | SVP, GC | A - Grant | $0.00 | +40.0K | 179.7K | +29% | $0 |
| DM | 2024-03-06 | 2024-03-05 | ADPT | Taylor Stacy L | SVP, GC | S - Sale | $3.43 | -13.4K | 172.9K | -7% | -$46.0K |
| 2024-03-06 | 2024-03-04 | ADPT | ROBINS HARLAN S | CSO | A - Grant | $0.00 | +354.6K | 1.02M | +53% | $0 | |
| 2024-03-06 | 2024-03-04 | ADPT | RUBINSTEIN JULIE | Pres | A - Grant | $0.00 | +175.0K | 511.8K | +52% | $0 | |
| M | 2024-03-06 | 2024-03-05 | ADPT | RUBINSTEIN JULIE | Pres | S - Sale | $3.47 | -39.1K | 486.2K | -7% | -$135.8K |
| 2024-03-06 | 2024-03-04 | ADPT | PISKEL KYLE | Principal Accounting Off | A - Grant | $0.00 | +43.7K | 131.0K | +50% | $0 | |
| 2024-03-06 | 2024-03-05 | ADPT | PISKEL KYLE | Principal Accounting Off | S - Sale | $3.43 | -7,727 | 123.3K | -6% | -$26.5K | |
| D | 2024-03-06 | 2024-03-04 | ADPT | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +31.3K | 52.0K | +152% | $0 |
| D | 2024-03-06 | 2024-03-04 | ADPT | OWEN KATEY EINTERZ | Dir | A - Grant | $0.00 | +31.3K | 57.2K | +121% | $0 |
| D | 2024-03-06 | 2024-03-04 | ADPT | NEUPERT PETER M | Dir | A - Grant | $0.00 | +31.3K | 154.3K | +25% | $0 |
| DM | 2024-03-06 | 2024-03-05 | ADPT | LO FRANCIS | CHRO | S - Sale | $3.43 | -14.7K | 253.7K | -5% | -$50.4K |
| D | 2024-03-06 | 2024-03-04 | ADPT | LO FRANCIS | CHRO | A - Grant | $0.00 | +100.0K | 268.4K | +59% | $0 |
| DM | 2024-03-06 | 2024-03-05 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | S - Sale | $3.44 | -29.4K | 346.1K | -8% | -$101.0K |
| D | 2024-03-06 | 2024-03-04 | ADPT | BENZENO SHARON | Chief Commercial Ofc Imm Med | A - Grant | $0.00 | +133.0K | 356.8K | +59% | $0 |
| DM | 2024-03-06 | 2024-03-05 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | S - Sale | $3.44 | -13.0K | 255.3K | -5% | -$44.6K |
| D | 2024-03-06 | 2024-03-04 | ADPT | BOBULSKY SUSAN | Chief Commercial Off, MRD | A - Grant | $0.00 | +133.0K | 261.3K | +104% | $0 |
| 2024-03-06 | 2024-03-05 | ADPT | PETERSON TYCHO | CFO | S - Sale | $3.44 | -15.5K | 531.6K | -3% | -$53.2K | |
| 2024-03-06 | 2024-03-04 | ADPT | PETERSON TYCHO | CFO | A - Grant | $0.00 | +147.8K | 547.0K | +37% | $0 | |
| M | 2024-03-06 | 2024-03-05 | ADPT | ROBINS CHAD M | CEO, COB, Dir | S - Sale | $3.43 | -48.7K | 2.58M | -2% | -$167.0K |
| 2024-03-06 | 2024-03-04 | ADPT | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +354.6K | 2.63M | +16% | $0 | |
| D | 2023-12-15 | 2023-12-13 | ADPT | NEUPERT PETER M | Dir | M - OptEx | $0.84 | +100.0K | 123.0K | +435% | +$84.0K |
| 2023-11-20 | 2023-11-16 | ADPT | PISKEL KYLE | Principal Accounting Off | S - Sale | $4.13 | -259 | 87.3K | -0.3% | -$1,070 | |
| M | 2023-08-08 | 2023-08-07+ | ADPT | SOOD NITIN | Chief Commercial Off, MRD | S - Sale | $6.62 | -16.2K | 225.4K | -7% | -$107.3K |
| DM | 2023-06-21 | 2023-06-20 | ADPT | PETERSON TYCHO | CFO | S - Sale+OE | $8.14 | -135.0K | 399.2K | -25% | -$1.10M |
| D | 2023-06-21 | 2023-06-20 | ADPT | PETERSON TYCHO | CFO | M - OptEx | $7.30 | +135.0K | 534.2K | +34% | +$985.2K |
| D | 2023-06-20 | 2023-06-15 | ADPT | PETERSON TYCHO | CFO | M - OptEx | $7.30 | +14.3K | 413.5K | +4% | +$104.6K |
| DM | 2023-06-20 | 2023-06-15 | ADPT | PETERSON TYCHO | CFO | S - Sale+OE | $8.53 | -70.0K | 399.2K | -15% | -$597.1K |
| 2023-06-06 | 2023-06-02 | ADPT | PETERSON TYCHO | CFO | S - Sale | $7.16 | -38.0K | 454.9K | -8% | -$272.1K | |
| M | 2023-04-12 | 2023-04-10+ | ADPT | ADAMS R MARK | COO | S - Sale | $8.60 | -3,125 | 177.7K | -2% | -$26.9K |
| 2023-03-29 | 2023-03-27 | ADPT | GRIFFIN MICHELLE RENEE | Dir | S - Sale | $8.49 | -2,341 | 20.6K | -10% | -$19.9K | |
| D | 2023-03-08 | 2023-03-06 | ADPT | Conroy Kevin T | Dir | A - Grant | $0.00 | +14.8K | 23.0K | +180% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | NEUPERT PETER M | Dir | A - Grant | $0.00 | +14.8K | 23.0K | +180% | $0 |
| D | 2023-03-08 | 2023-03-06 | ADPT | Trigg Leslie | Dir | A - Grant | $0.00 | +14.8K | 25.9K | +133% | $0 |
| DM | 2023-03-08 | 2023-03-06+ | ADPT | SOOD NITIN | Chief Commercial Off, MRD | S - Sale | $8.59 | -16.5K | 231.0K | -7% | -$141.5K |
| D | 2023-03-08 | 2023-03-06 | ADPT | SOOD NITIN | Chief Commercial Off, MRD | A - Grant | $0.00 | +133.0K | 247.5K | +116% | $0 |
| 2023-03-08 | 2023-03-06 | ADPT | ROBINS CHAD M | CEO, COB, Dir | A - Grant | $0.00 | +354.6K | 2.27M | +19% | $0 | |
| D | 2023-03-08 | 2023-03-06 | ADPT | OWEN KATEY EINTERZ | Dir | A - Grant | $0.00 | +14.8K | 25.9K | +133% | $0 |
| DM | 2023-03-08 | 2023-03-06+ | ADPT | ADAMS R MARK | COO | S - Sale | $8.59 | -23.7K | 195.6K | -11% | -$203.5K |
| D | 2023-03-08 | 2023-03-06 | ADPT | ADAMS R MARK | COO | A - Grant | $0.00 | +88.7K | 202.2K | +78% | $0 |
Purchase Sale Sale after option exercise All abbreviations